Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NaPPS versus placebo in knee osteoarthritis
jRCT2071210131Active, not recruiting
- Sponsor
- ReqMed Company, Ltd.
- Start
- Mar 2022
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Randomised, double-blind trial in knee osteoarthritis (OA) comparing NaPPS with Placebo (2 arms). Primary endpoint: WOMAC overall score change. Started Mar 2022; status: active, not recruiting.
02
Drugs
pentosan polysulfate sodium
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on jRCT2071210131.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2071210131.